R2202126 |
AZD9056 hydrochloride |
AZD9056 hydrochloride is a selective orally active inhibitor of P2X7 which plays
|
R2202127 |
UCB-9260 |
UCB-9260, an orally active compound, inhibits TNF signaling by stabilising an as
|
R2202128 |
LM22A-4 |
LM22A-4 is a specific agonist of tyrosine kinase receptor B, used for neurologic
|
R2202129 |
BI-4464 |
BI-4464 is a highly selective ATP competitive inhibitor of PTK2/FAK, with an IC5
|
R2204281 |
Brusatol |
Brusatol (NSC 172924) is a unique inhibitor of the Nrf2 pathway t
|
R2202132 |
Besifovir (LB8033) |
Besifovir (LB80331), a parent drug converted by LB80380, further metabolizes to
|
R2202133 |
Cichoric Acid |
Cichoric Acid, a natural product, is reported to be antioxidative.
|
R2202134 |
BMS-P5 hydrochloride |
BMS-P5 is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhib
|
R2202135 |
Letrozole |
Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-s
|
R2202136 |
Anastrozole |
Anastrozole is a potent, highly selective aromatase inhibitor, which inhibits hu
|
R2202137 |
Glibenclamide impurity Ⅱ |
Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) in
|
R2202138 |
FM-479 |
FM-479 is the negative control of FM-381 (HY-102046) and has no activity on JAK3
|
R2202139 |
T56-LIMKi |
T56-LIMKi is a selective inhibitor of LIMK2; inhibits the growth of Panc-1 cells
|
R2202140 |
INE963 |
4-Piperidinol, 4-(aminomethyl)-1-[5-[2-methoxy-6-(1-methylethyl)-3-pyridinyl]imi
|
R2202141 |
JQKD-82 |
JQKD82 (JADA82) is a cell-permeable and selective KDM5 inhibitor. JQKD82 increas
|
R2202142 |
SKF89976A hydrochloride |
SKF89976A hydrochloride is a selective GABA transporter (GAT-1) inhibitor with I
|
R2202143 |
Complement factor D-IN-2 |
Complement factor D-IN-2 is an inhibitor of complement factor D extracted from p
|
R2202144 |
SR1664 |
SR1664 is a PPARγ antagonist. SR1664 binds to PPARγ and potently inhibits Cdk5-m
|
R2202145 |
Bocidelpar |
Bocidelpar is a modulator of peroxisome proliferator-activated receptor del
|
R2202146 |
ML339 |
ML339 is a potent and selective CXCR6 (IC50 of 140 nM) antagonist that is select
|
R2202147 |
SCD1 inhibitor-3 |
SCD1 inhibitor-3 is a safe, potent and orally active SCD1 inhibitor. SCD1 inhibi
|
R2202148 |
YTX-465 |
YTX-465 is a stearoyl-CoA desaturase (Ole1/SCD) inhibitor. YTX-465 inhibits Ole1
|
R2202149 |
BMS-615 |
TLR7/8/9-IN-1 is a potent and orally bioavailable small molecule antagonist (IC5
|
R2202150 |
VU6015929 |
VU6015929 is a potent, selective and orally active dual discoidin domain re
|
R2202151 |
Tavapadon |
Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5
|